| Colon cancer stem cells: promise of targeted therapy M Todaro, MG Francipane, JP Medema, G Stassi Gastroenterology 138 (6), 2151-2162, 2010 | 558 | 2010 |
| Efficient killing of human colon cancer stem cells by γδ T lymphocytes M Todaro, M D'Asaro, N Caccamo, F Iovino, MG Francipane, S Meraviglia, ... The Journal of Immunology 182 (11), 7287-7296, 2009 | 364 | 2009 |
| Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4 M Todaro, Y Lombardo, MG Francipane, MP Alea, P Cammareri, F Iovino, ... Cell Death & Differentiation 15 (4), 762-772, 2008 | 268 | 2008 |
| mTOR pathway in colorectal cancer: an update MG Francipane, E Lagasse Oncotarget 5 (1), 49-66, 2014 | 187 | 2014 |
| Crucial role of interleukin-4 in the survival of colon cancer stem cells MG Francipane, M Perez Alea, Y Lombardo, M Todaro, JP Medema, ... Cancer research 68 (11), 4022-4025, 2008 | 149 | 2008 |
| Isolation and culture of colon cancer stem cells P Cammareri, Y Lombardo, MG Francipane, S Bonventre, M Todaro, ... Methods in cell biology 86, 311-324, 2008 | 122 | 2008 |
| Selective targeting of human colon cancer stem-like cells by the mTOR inhibitor Torin-1 MG Francipane, E Lagasse Oncotarget 4 (11), 1948, 2013 | 101 | 2013 |
| Suppressor of cytokine signaling 3 sensitizes anaplastic thyroid cancer to standard chemotherapy MG Francipane, V Eterno, V Spina, M Bini, G Scerrino, G Buscemi, ... Cancer research 69 (15), 6141-6148, 2009 | 51 | 2009 |
| MUC1 oncoprotein promotes refractoriness to chemotherapy in thyroid cancer cells M Siragusa, M Zerilli, F Iovino, MG Francipane, Y Lombardo, ... Cancer research 67 (11), 5522-5530, 2007 | 42 | 2007 |
| Establishment and Characterization of 5-Fluorouracil-Resistant Human Colorectal Cancer Stem-Like Cells: Tumor Dynamics under Selection Pressure MG Francipane, D Bulanin, E Lagasse International Journal of Molecular Sciences, 2019 | 36 | 2019 |
| Cancer stem cells: a moving target MG Francipane, JM Chandler, E Lagasse Current pathobiology reports 1, 111-118, 2013 | 32 | 2013 |
| Therapeutic potential of mTOR inhibitors for targeting cancer stem cells MG Francipane, E Lagasse Br J Clin Pharmacol., 2015 | 31 | 2015 |
| Moving Towards Induced Pluripotent Stem Cell-based Therapies with Artificial Intelligence and Machine Learning C Coronnello, MG Francipane Stem Cell Reviews and Reports, 2021 | 27 | 2021 |
| The Lymph Node as a New Site for Kidney Organogenesis MG Francipane, E Lagasse Stem Cells Translational Medicine 4, 1-13, 2015 | 23 | 2015 |
| Zika Virus: A New Therapeutic Candidate for Glioblastoma Treatment MG Francipane, B Douradinha, CM Chinnici, G Russelli, PG Conaldi, ... International Journal of Molecular Sciences 22 (20), 2021 | 17 | 2021 |
| Kidney‐in‐a‐lymph node: a novel organogenesis assay to model human renal development and test nephron progenitor cell fates MG Francipane, B Han, L Oxburgh, S Sims-Lucas, Z Li, E Lagasse Journal of Tissue Engineering and Regenerative Medicine 13 (9), 1724-1731, 2019 | 16 | 2019 |
| Maturation of Embryonic Tissues in a Lymph Node: a New Approach for Bioengineering Complex Organs MG Francipane, E Lagasse Organogenesis 10 (3), 323-31, 2014 | 16 | 2014 |
| Toward organs on demand: breakthroughs and challenges in models of organogenesis MG Francipane, E Lagasse Current Pathobiology Reports, 1-9, 2016 | 15 | 2016 |
| Ex vivo cell therapy by ectopic hepatocyte transplantation treats the porcine tyrosinemia model of acute liver failure CT Nicolas, RA Kaiser, RD Hickey, KL Allen, Z Du, CJ VanLith, ... Molecular Therapy-Methods & Clinical Development 18, 738-750, 2020 | 11 | 2020 |
| Pluripotent stem cells to rebuild a kidney: the lymph node as a possible developmental niche MG Francipane, E Lagasse Cell Transplantation, 2015 | 9 | 2015 |
